Risk of Symptomatic Intracranial Hemorrhage After Mechanical Thrombectomy in Randomized Clinical Trials: A Systematic Review and Meta-Analysis

Overview

Journal Brain Sci

Publisher MDPI

Date 2025 Jan 24

PMID 39851431

Authors

Abdullah Reda

Alireza Hasanzadeh

Sherief Ghozy

Hossein Sanjari Moghaddam

Tanin Adl Parvar

Mohsen Motevaselian

Ramanathan Kadirvel

David F Kallmes

Alejandro Rabinstein

Affiliations

Soon will be listed here.

Abstract

Background: Symptomatic intracranial hemorrhage (sICH) is the most dreaded complication after reperfusion therapy for acute ischemic stroke. We performed a meta-analysis of randomized controlled trials to estimate and compare risks of sICH after mechanical thrombectomy (MT) depending on the location of the large vessel occlusion, concomitant use of intravenous thrombolysis, timing of treatment, and core size.

Methods: Randomized controlled trials were included, following a comprehensive search of different databases from inception to 1 March 2024. Random-effect models in a meta-analysis were employed to obtain the pooled risk ratios (RRs) and their corresponding 95% confidence intervals (95% CI) for sICH with MT, and were then compared to other reperfusion treatment regimens, including best medical treatment and intravenous thrombolysis (IVT).

Results: MT in the anterior circulation was associated with a significantly higher risk of sICH as compared with no-MT (RR: 1.46; 95%CI: 1.03-2.07; = 0.037). The risk of sICH was comparable between the MT and MT+IVT groups (RR: 0.77; 95%CI: 0.57-1.03; 0.079). There was no difference in sICH risk with MT as compared with no-MT within 6 h of last known well (RR: 1.14; 95%CI: 0.78-1.66; = 0.485) and beyond that time (RR: 1.29; 95%CI: 0.80-2.08; = 0.252); the risk of sICH was also comparable between MT conducted within 6 h of last known well and MT conducted beyond that time ( = 0.512). The sICH risk for MT in the posterior circulation (RR: 7.48; 95%CI: 2.27-24.61) was significantly higher than for MT in the anterior circulation (RR: 1.18; 95%CI: 0.90-1.56) ( = 0.003). MT was also associated with a significantly higher sICH risk than no-MT among patients with large core strokes (RR: 1.71; 95%CI: 1.09-2.66, = 0.018).

Conclusions: When evaluating cumulative evidence from randomized controlled trials, the risk of sICH is increased after MT compared with patients not treated with MT. Yet, the difference is largely driven by the greater risk of sICH in patients treated with MT for posterior circulation occlusions and, to a lesser degree, large core strokes. Concomitant use of intravenous thrombolysis and the use of MT in the extended therapeutic window do not raise the risk of sICH.

References

Tao C, Nogueira R, Zhu Y, Sun J, Han H, Yuan G . Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion. N Engl J Med. 2022; 387(15):1361-1372. DOI: 10.1056/NEJMoa2206317. View

Sarraj A, Hassan A, Abraham M, Ortega-Gutierrez S, Kasner S, Hussain M . Trial of Endovascular Thrombectomy for Large Ischemic Strokes. N Engl J Med. 2023; 388(14):1259-1271. DOI: 10.1056/NEJMoa2214403. View

Mitchell P, Yan B, Churilov L, Dowling R, Bush S, Bivard A . Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial. Lancet. 2022; 400(10346):116-125. DOI: 10.1016/S0140-6736(22)00564-5. View

Jovin T, Chamorro A, Cobo E, de Miquel M, Molina C, Rovira A . Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015; 372(24):2296-306. DOI: 10.1056/NEJMoa1503780. View

Morsi R, Zhang Y, Carrion-Penagos J, Desai H, Tannous E, Kothari S . Endovascular Thrombectomy With or Without Thrombolysis for Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Neurohospitalist. 2024; 14(1):23-33. PMC: 10790620. DOI: 10.1177/19418744231200046. View

Goyal M, Menon B, van Zwam W, Dippel D, Mitchell P, Demchuk A . Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016; 387(10029):1723-31. DOI: 10.1016/S0140-6736(16)00163-X. View

Trifan G, Biller J, Testai F . Mechanical Thrombectomy vs Bridging Therapy for Anterior Circulation Large Vessel Occlusion Stroke: Systematic Review and Meta-analysis. Neurology. 2022; 98(13):e1361-e1373. DOI: 10.1212/WNL.0000000000200029. View

Tao C, Qureshi A, Yin Y, Li J, Li R, Xu P . Endovascular Treatment Versus Best Medical Management in Acute Basilar Artery Occlusion Strokes: Results From the ATTENTION Multicenter Registry. Circulation. 2022; 146(1):6-17. DOI: 10.1161/CIRCULATIONAHA.121.058544. View

Chen Y, Zhou S, Yang S, Mofatteh M, Hu Y, Wei H . Developing and predicting of early mortality after endovascular thrombectomy in patients with acute ischemic stroke. Front Neurosci. 2023; 16:1034472. PMC: 9810273. DOI: 10.3389/fnins.2022.1034472. View

10.

Saver J, Goyal M, Bonafe A, Diener H, Levy E, Pereira V . Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015; 372(24):2285-95. DOI: 10.1056/NEJMoa1415061. View

11.

Hou X, Feng X, Wang H, Li Q . Mechanical Thrombectomy for Mild Acute Ischemic Stroke with Large-Vessel Occlusion: A Systematic Review and Meta-Analysis. Cerebrovasc Dis. 2022; 51(5):615-622. DOI: 10.1159/000523838. View

12.

Zhang L, Lu H, Yang C . Global, regional, and national burden of stroke from 1990 to 2019: A temporal trend analysis based on the Global Burden of Disease Study 2019. Int J Stroke. 2024; 19(6):686-694. DOI: 10.1177/17474930241246955. View

13.

Yaghi S, Willey J, Cucchiara B, Goldstein J, Gonzales N, Khatri P . Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in Acute Ischemic Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2017; 48(12):e343-e361. DOI: 10.1161/STR.0000000000000152. View

14.

Li Y, Chen S, Bao Q, Yang M, Li J . Real-world safety and efficacy endovascular treatment versus standard medical treatment for basilar artery occlusion: A systematic review and meta-analysis. Clin Neurol Neurosurg. 2024; 236:108096. DOI: 10.1016/j.clineuro.2023.108096. View

15.

Renu A, Millan M, San Roman L, Blasco J, Marti-Fabregas J, Terceno M . Effect of Intra-arterial Alteplase vs Placebo Following Successful Thrombectomy on Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke: The CHOICE Randomized Clinical Trial. JAMA. 2022; 327(9):826-835. PMC: 8832304. DOI: 10.1001/jama.2022.1645. View

16.

Bendszus M, Fiehler J, Subtil F, Bonekamp S, Aamodt A, Fuentes B . Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial. Lancet. 2023; 402(10414):1753-1763. DOI: 10.1016/S0140-6736(23)02032-9. View

17.

Majoie C, Cavalcante F, Gralla J, Yang P, Kaesmacher J, Treurniet K . Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials. Lancet. 2023; 402(10406):965-974. DOI: 10.1016/S0140-6736(23)01142-X. View

18.

Albers G, Marks M, Kemp S, Christensen S, Tsai J, Ortega-Gutierrez S . Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018; 378(8):708-718. PMC: 6590673. DOI: 10.1056/NEJMoa1713973. View

19.

Zhang X, Xie Y, Wang H, Yang D, Jiang T, Yuan K . Symptomatic Intracranial Hemorrhage After Mechanical Thrombectomy in Chinese Ischemic Stroke Patients: The ASIAN Score. Stroke. 2020; 51(9):2690-2696. DOI: 10.1161/STROKEAHA.120.030173. View

20.

Liberati A, Altman D, Tetzlaff J, Mulrow C, Gotzsche P, Ioannidis J . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009; 6(7):e1000100. PMC: 2707010. DOI: 10.1371/journal.pmed.1000100. View